Login / Signup

Combination therapy with atorvastatin and celecoxib delays tumor formation in a Fanconi anemia mouse model.

Qing-Shuo ZhangMatthew DeaterNgoc PhanAndrea MarcoglieseAngela MajorEva C GuinanMarkus Grompe
Published in: Pediatric blood & cancer (2018)
The data presented here suggest that a combination of atorvastatin and celecoxib may be a good candidate for chemoprevention in Fanconi anemia.
Keyphrases
  • combination therapy
  • mouse model
  • iron deficiency
  • chronic kidney disease
  • electronic health record
  • big data
  • deep learning